Be a Smart Investor
Wednesday, August 9, 2017
Ligand Pharmaceuticals Inc. (LGND) Climbed To A New High On Q2 Results
Ligand Pharmaceuticals Inc. (LGND) reported second quarter EPS of $0.67 after the bell Monday, up from $0.35 in the prior year period.
from RTT - Before the Bell http://ift.tt/2fturzV
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment